Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Depression Medicine Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Tricyclic Antidepressants
1.2.3 Serotonin-norepinephrine Inhibitors
1.2.4 Atypical Antipsychotics
1.2.5 Selective Serotonin Reuptake Inhibitors
1.2.6 Benzodiazepines
1.2.7 Tetracyclic Antidepressants
1.2.8 Monoamine Oxidase Inhibitors
1.2.9 Others
1.3 Market by Application
1.3.1 Global Depression Medicine Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Depression Medicine Market Perspective (2018-2034)
2.2 Depression Medicine Growth Trends by Region
2.2.1 Global Depression Medicine Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Depression Medicine Historic Market Size by Region (2018-2023)
2.2.3 Depression Medicine Forecasted Market Size by Region (2024-2034)
2.3 Depression Medicine Market Dynamics
2.3.1 Depression Medicine Industry Trends
2.3.2 Depression Medicine Market Drivers
2.3.3 Depression Medicine Market Challenges
2.3.4 Depression Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Depression Medicine Players by Revenue
3.1.1 Global Top Depression Medicine Players by Revenue (2018-2023)
3.1.2 Global Depression Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Depression Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Depression Medicine Revenue
3.4 Global Depression Medicine Market Concentration Ratio
3.4.1 Global Depression Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Depression Medicine Revenue in 2024
3.5 Depression Medicine Key Players Head office and Area Served
3.6 Key Players Depression Medicine Product Solution and Service
3.7 Date of Enter into Depression Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Depression Medicine Breakdown Data by Type
4.1 Global Depression Medicine Historic Market Size by Type (2018-2023)
4.2 Global Depression Medicine Forecasted Market Size by Type (2024-2034)
5 Depression Medicine Breakdown Data by Application
5.1 Global Depression Medicine Historic Market Size by Application (2018-2023)
5.2 Global Depression Medicine Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Depression Medicine Market Size (2018-2034)
6.2 North America Depression Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Depression Medicine Market Size by Country (2018-2023)
6.4 North America Depression Medicine Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Depression Medicine Market Size (2018-2034)
7.2 Europe Depression Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Depression Medicine Market Size by Country (2018-2023)
7.4 Europe Depression Medicine Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Depression Medicine Market Size (2018-2034)
8.2 Asia-Pacific Depression Medicine Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Depression Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Depression Medicine Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Depression Medicine Market Size (2018-2034)
9.2 Latin America Depression Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Depression Medicine Market Size by Country (2018-2023)
9.4 Latin America Depression Medicine Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Depression Medicine Market Size (2018-2034)
10.2 Middle East & Africa Depression Medicine Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Depression Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Depression Medicine Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Depression Medicine Introduction
11.1.4 Pfizer Revenue in Depression Medicine Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Depression Medicine Introduction
11.2.4 AstraZeneca Revenue in Depression Medicine Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Detail
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Depression Medicine Introduction
11.3.4 Eli Lilly and Company Revenue in Depression Medicine Business (2018-2023)
11.3.5 Eli Lilly and Company Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Depression Medicine Introduction
11.4.4 Novartis Revenue in Depression Medicine Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Depression Medicine Introduction
11.5.4 GlaxoSmithKline Revenue in Depression Medicine Business (2018-2023)
11.5.5 GlaxoSmithKline Recent Development
11.6 Otsuka Pharmaceutical
11.6.1 Otsuka Pharmaceutical Company Detail
11.6.2 Otsuka Pharmaceutical Business Overview
11.6.3 Otsuka Pharmaceutical Depression Medicine Introduction
11.6.4 Otsuka Pharmaceutical Revenue in Depression Medicine Business (2018-2023)
11.6.5 Otsuka Pharmaceutical Recent Development
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Detail
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Depression Medicine Introduction
11.7.4 Abbott Laboratories Revenue in Depression Medicine Business (2018-2023)
11.7.5 Abbott Laboratories Recent Development
11.8 Gedeon Richter
11.8.1 Gedeon Richter Company Detail
11.8.2 Gedeon Richter Business Overview
11.8.3 Gedeon Richter Depression Medicine Introduction
11.8.4 Gedeon Richter Revenue in Depression Medicine Business (2018-2023)
11.8.5 Gedeon Richter Recent Development
11.9 Janssen Pharmaceuticals
11.9.1 Janssen Pharmaceuticals Company Detail
11.9.2 Janssen Pharmaceuticals Business Overview
11.9.3 Janssen Pharmaceuticals Depression Medicine Introduction
11.9.4 Janssen Pharmaceuticals Revenue in Depression Medicine Business (2018-2023)
11.9.5 Janssen Pharmaceuticals Recent Development
11.10 Lupin Pharmaceuticals
11.10.1 Lupin Pharmaceuticals Company Detail
11.10.2 Lupin Pharmaceuticals Business Overview
11.10.3 Lupin Pharmaceuticals Depression Medicine Introduction
11.10.4 Lupin Pharmaceuticals Revenue in Depression Medicine Business (2018-2023)
11.10.5 Lupin Pharmaceuticals Recent Development
11.11 Luye Pharma
11.11.1 Luye Pharma Company Detail
11.11.2 Luye Pharma Business Overview
11.11.3 Luye Pharma Depression Medicine Introduction
11.11.4 Luye Pharma Revenue in Depression Medicine Business (2018-2023)
11.11.5 Luye Pharma Recent Development
11.12 MSI Methylation Sciences
11.12.1 MSI Methylation Sciences Company Detail
11.12.2 MSI Methylation Sciences Business Overview
11.12.3 MSI Methylation Sciences Depression Medicine Introduction
11.12.4 MSI Methylation Sciences Revenue in Depression Medicine Business (2018-2023)
11.12.5 MSI Methylation Sciences Recent Development
11.13 Naurex
11.13.1 Naurex Company Detail
11.13.2 Naurex Business Overview
11.13.3 Naurex Depression Medicine Introduction
11.13.4 Naurex Revenue in Depression Medicine Business (2018-2023)
11.13.5 Naurex Recent Development
11.14 SK Biopharmaceuticals
11.14.1 SK Biopharmaceuticals Company Detail
11.14.2 SK Biopharmaceuticals Business Overview
11.14.3 SK Biopharmaceuticals Depression Medicine Introduction
11.14.4 SK Biopharmaceuticals Revenue in Depression Medicine Business (2018-2023)
11.14.5 SK Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Depression Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Tricyclic Antidepressants
Table 3. Key Players of Serotonin-norepinephrine Inhibitors
Table 4. Key Players of Atypical Antipsychotics
Table 5. Key Players of Selective Serotonin Reuptake Inhibitors
Table 6. Key Players of Benzodiazepines
Table 7. Key Players of Tetracyclic Antidepressants
Table 8. Key Players of Monoamine Oxidase Inhibitors
Table 9. Key Players of Others
Table 10. Global Depression Medicine Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 11. Global Depression Medicine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 12. Global Depression Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Depression Medicine Market Share by Region (2018-2023)
Table 14. Global Depression Medicine Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 15. Global Depression Medicine Market Share by Region (2024-2034)
Table 16. Depression Medicine Market Trends
Table 17. Depression Medicine Market Drivers
Table 18. Depression Medicine Market Challenges
Table 19. Depression Medicine Market Restraints
Table 20. Global Depression Medicine Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Depression Medicine Market Share by Players (2018-2023)
Table 22. Global Top Depression Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depression Medicine as of 2024)
Table 23. Ranking of Global Top Depression Medicine Companies by Revenue (US$ Million) in 2024
Table 24. Global 5 Largest Players Market Share by Depression Medicine Revenue (CR5 and HHI) & (2018-2023)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Depression Medicine Product Solution and Service
Table 27. Date of Enter into Depression Medicine Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Depression Medicine Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Depression Medicine Revenue Market Share by Type (2018-2023)
Table 31. Global Depression Medicine Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 32. Global Depression Medicine Revenue Market Share by Type (2024-2034)
Table 33. Global Depression Medicine Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Depression Medicine Revenue Market Share by Application (2018-2023)
Table 35. Global Depression Medicine Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 36. Global Depression Medicine Revenue Market Share by Application (2024-2034)
Table 37. North America Depression Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. North America Depression Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Depression Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 40. Europe Depression Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Europe Depression Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 42. Europe Depression Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 43. Asia-Pacific Depression Medicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 44. Asia-Pacific Depression Medicine Market Size by Region (2018-2023) & (US$ Million)
Table 45. Asia-Pacific Depression Medicine Market Size by Region (2024-2034) & (US$ Million)
Table 46. Latin America Depression Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 47. Latin America Depression Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 48. Latin America Depression Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 49. Middle East & Africa Depression Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 50. Middle East & Africa Depression Medicine Market Size by Country (2018-2023) & (US$ Million)
Table 51. Middle East & Africa Depression Medicine Market Size by Country (2024-2034) & (US$ Million)
Table 52. Pfizer Company Detail
Table 53. Pfizer Business Overview
Table 54. Pfizer Depression Medicine Product
Table 55. Pfizer Revenue in Depression Medicine Business (2018-2023) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. AstraZeneca Company Detail
Table 58. AstraZeneca Business Overview
Table 59. AstraZeneca Depression Medicine Product
Table 60. AstraZeneca Revenue in Depression Medicine Business (2018-2023) & (US$ Million)
Table 61. AstraZeneca Recent Development
Table 62. Eli Lilly and Company Company Detail
Table 63. Eli Lilly and Company Business Overview
Table 64. Eli Lilly and Company Depression Medicine Product
Table 65. Eli Lilly and Company Revenue in Depression Medicine Business (2018-2023) & (US$ Million)
Table 66. Eli Lilly and Company Recent Development
Table 67. Novartis Company Detail
Table 68. Novartis Business Overview
Table 69. Novartis Depression Medicine Product
Table 70. Novartis Revenue in Depression Medicine Business (2018-2023) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. GlaxoSmithKline Company Detail
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Depression Medicine Product
Table 75. GlaxoSmithKline Revenue in Depression Medicine Business (2018-2023) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Otsuka Pharmaceutical Company Detail
Table 78. Otsuka Pharmaceutical Business Overview
Table 79. Otsuka Pharmaceutical Depression Medicine Product
Table 80. Otsuka Pharmaceutical Revenue in Depression Medicine Business (2018-2023) & (US$ Million)
Table 81. Otsuka Pharmaceutical Recent Development
Table 82. Abbott Laboratories Company Detail
Table 83. Abbott Laboratories Business Overview
Table 84. Abbott Laboratories Depression Medicine Product
Table 85. Abbott Laboratories Revenue in Depression Medicine Business (2018-2023) & (US$ Million)
Table 86. Abbott Laboratories Recent Development
Table 87. Gedeon Richter Company Detail
Table 88. Gedeon Richter Business Overview
Table 89. Gedeon Richter Depression Medicine Product
Table 90. Gedeon Richter Revenue in Depression Medicine Business (2018-2023) & (US$ Million)
Table 91. Gedeon Richter Recent Development
Table 92. Janssen Pharmaceuticals Company Detail
Table 93. Janssen Pharmaceuticals Business Overview
Table 94. Janssen Pharmaceuticals Depression Medicine Product
Table 95. Janssen Pharmaceuticals Revenue in Depression Medicine Business (2018-2023) & (US$ Million)
Table 96. Janssen Pharmaceuticals Recent Development
Table 97. Lupin Pharmaceuticals Company Detail
Table 98. Lupin Pharmaceuticals Business Overview
Table 99. Lupin Pharmaceuticals Depression Medicine Product
Table 100. Lupin Pharmaceuticals Revenue in Depression Medicine Business (2018-2023) & (US$ Million)
Table 101. Lupin Pharmaceuticals Recent Development
Table 102. Luye Pharma Company Detail
Table 103. Luye Pharma Business Overview
Table 104. Luye Pharma Depression Medicine Product
Table 105. Luye Pharma Revenue in Depression Medicine Business (2018-2023) & (US$ Million)
Table 106. Luye Pharma Recent Development
Table 107. MSI Methylation Sciences Company Detail
Table 108. MSI Methylation Sciences Business Overview
Table 109. MSI Methylation Sciences Depression Medicine Product
Table 110. MSI Methylation Sciences Revenue in Depression Medicine Business (2018-2023) & (US$ Million)
Table 111. MSI Methylation Sciences Recent Development
Table 112. Naurex Company Detail
Table 113. Naurex Business Overview
Table 114. Naurex Depression Medicine Product
Table 115. Naurex Revenue in Depression Medicine Business (2018-2023) & (US$ Million)
Table 116. Naurex Recent Development
Table 117. SK Biopharmaceuticals Company Detail
Table 118. SK Biopharmaceuticals Business Overview
Table 119. SK Biopharmaceuticals Depression Medicine Product
Table 120. SK Biopharmaceuticals Revenue in Depression Medicine Business (2018-2023) & (US$ Million)
Table 121. SK Biopharmaceuticals Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Depression Medicine Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Depression Medicine Market Share by Type: 2024 VS 2034
Figure 3. Tricyclic Antidepressants Features
Figure 4. Serotonin-norepinephrine Inhibitors Features
Figure 5. Atypical Antipsychotics Features
Figure 6. Selective Serotonin Reuptake Inhibitors Features
Figure 7. Benzodiazepines Features
Figure 8. Tetracyclic Antidepressants Features
Figure 9. Monoamine Oxidase Inhibitors Features
Figure 10. Others Features
Figure 11. Global Depression Medicine Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 12. Global Depression Medicine Market Share by Application: 2024 VS 2034
Figure 13. Hospitals Case Studies
Figure 14. Clinics Case Studies
Figure 15. Others Case Studies
Figure 16. Depression Medicine Report Years Considered
Figure 17. Global Depression Medicine Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 18. Global Depression Medicine Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 19. Global Depression Medicine Market Share by Region: 2024 VS 2034
Figure 20. Global Depression Medicine Market Share by Players in 2024
Figure 21. Global Top Depression Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depression Medicine as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Depression Medicine Revenue in 2024
Figure 23. North America Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. North America Depression Medicine Market Share by Country (2018-2034)
Figure 25. United States Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Canada Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Europe Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Europe Depression Medicine Market Share by Country (2018-2034)
Figure 29. Germany Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. France Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. U.K. Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Italy Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Russia Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Nordic Countries Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Asia-Pacific Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Asia-Pacific Depression Medicine Market Share by Region (2018-2034)
Figure 37. China Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Japan Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. South Korea Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Southeast Asia Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. India Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Australia Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Latin America Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Latin America Depression Medicine Market Share by Country (2018-2034)
Figure 45. Mexico Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Brazil Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Middle East & Africa Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Depression Medicine Market Share by Country (2018-2034)
Figure 49. Turkey Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 50. Saudi Arabia Depression Medicine Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 51. Pfizer Revenue Growth Rate in Depression Medicine Business (2018-2023)
Figure 52. AstraZeneca Revenue Growth Rate in Depression Medicine Business (2018-2023)
Figure 53. Eli Lilly and Company Revenue Growth Rate in Depression Medicine Business (2018-2023)
Figure 54. Novartis Revenue Growth Rate in Depression Medicine Business (2018-2023)
Figure 55. GlaxoSmithKline Revenue Growth Rate in Depression Medicine Business (2018-2023)
Figure 56. Otsuka Pharmaceutical Revenue Growth Rate in Depression Medicine Business (2018-2023)
Figure 57. Abbott Laboratories Revenue Growth Rate in Depression Medicine Business (2018-2023)
Figure 58. Gedeon Richter Revenue Growth Rate in Depression Medicine Business (2018-2023)
Figure 59. Janssen Pharmaceuticals Revenue Growth Rate in Depression Medicine Business (2018-2023)
Figure 60. Lupin Pharmaceuticals Revenue Growth Rate in Depression Medicine Business (2018-2023)
Figure 61. Luye Pharma Revenue Growth Rate in Depression Medicine Business (2018-2023)
Figure 62. MSI Methylation Sciences Revenue Growth Rate in Depression Medicine Business (2018-2023)
Figure 63. Naurex Revenue Growth Rate in Depression Medicine Business (2018-2023)
Figure 64. SK Biopharmaceuticals Revenue Growth Rate in Depression Medicine Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed